Sionillo, Perla P.

HRN: 21-53-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2022
CEFTRIAXONE 1G (VIAL)
07/16/2022
07/23/2022
IV
2g
OD
CAP
Waiting Final Action 
07/20/2022
MUPIROCIN 2%, 15G (TUBE)
07/20/2022
07/27/2022
TOPICA
2%
TID
Pressure Ulcer
Waiting Final Action 
07/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/25/2022
07/31/2022
IV
4.5g
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: